MRNA is up roughly +103% to about $127.89 versus Tuesday's $62.96 close, with the surge beginning in premarket trading. The catalyst: Moderna and Merck announced their Phase 3 INTerpath-001 trial met its primary goal, with the personalized mRNA cancer vaccine intismeran plus Keytruda significantly improving recurrence-free survival in high-risk melanoma.

AEHR fell -7.08% intraday to roughly $114.53, extending the prior session's -15.4% slide. The drop occurred during regular trading hours amid a broad AI/semiconductor sell-off.

NBIS is down -9.36% during regular market hours, last near $225.17 versus a prior close of $248.43. Primary catalyst: a pre-market announcement of a proposed $4.5 billion convertible senior notes offering ($2.75B due 2030, $1.75B due 2034), plus exchange agreements tied to existing 2029/2031 notes.

BTBT is trading down roughly -14.48% intraday to about $1.24 from its $1.45 prior close, with the decline occurring during regular market hours. The sell-off extends post-earnings weakness: Q2 results on Aug. 13 showed a -$0.31 per-share loss, badly missing the -$0.05 consensus, and Northland Securities subsequently cut its Q3 estimates.

WYFI dropped -25.01% to $20.30 from the prior session's $27.07 close, extending a roughly -22% pre-market slump into regular trading. The slide followed pricing of an upsized $270 million convertible senior notes offering (raised from $250 million), carrying a 5% coupon due 2032.

MRNA is surging +85.17% in the session, climbing from a $62.96 prior close to roughly $116.58. The move ignited in premarket trading and extended into regular hours on positive clinical news.

The stock price target in focus is $150 , roughly 29% above Newmont's recent level near $116 and above its 52-week high of $134.88. The strongest bullish factors are record gold prices near $4,900 per ounce, a new $6 billion share buyback, and a refreshed leadership agenda.

The widely discussed price objective for RKLB is $100 per share, roughly 26% above its most recent closing price near $79. Bullish drivers include rapid revenue growth, a record government contract backlog, and the upcoming Neutron medium-lift rocket.

Super Micro Computer ( SMCI ) last traded near $37, with a widely discussed $50 price target representing roughly 34% upside. The strongest bullish case rests on record AI-server demand, a $60 billion-plus order backlog, and aggressive fiscal 2027 revenue guidance.

Beta Technologies (BETA) shares climbed from $17.76 to $26.76 over roughly 30 days, a gain of about 50.7%. The rally accelerated after the July 20 unveiling of the MV250 autonomous hybrid-electric military aircraft and progress on hybrid-electric flight milestones.

Aura Minerals (AUGO) shares climbed roughly 52% over the last 30 days, rising from about $50.22 to $76.24, following its second-quarter 2026 earnings release. The advance was fueled by record first-half production, record quarterly net income, and new share-buyback and dividend announcements.

CHYM shares advanced about 45.5% over the 30 days through the Aug. 18, 2026 close, rising from $21.93 on July 20 to $31.91. The move was driven by second-quarter results that beat expectations and by raised full-year guidance.

Zebra Technologies closed at $366.42 on August 18, 2026, up about 38% from the July 20, 2026 close of $264.69. The advance was powered by a much stronger-than-expected Q2 2026 report released August 4, including revenue of $1.56 billion and adjusted EPS of $6.35.

Unity Software shares advanced about 56.8% over the 30 days through August 18, 2026, rising from a July 20 closing price of $29.81 to $46.74. The move was powered by a Q2 2026 earnings beat on August 6, with revenue of $546.47 million, up 24% year over year, and adjusted EBITDA of $160 million.

SQQQ declined approximately 10.5% over the past 30 days, based on the latest available close of $38.28 versus $42.79 about 30 calendar days earlier. The fund fell roughly 13.7% over the trailing quarter, even after a sharp late-July rally, as the Nasdaq-100 recovered from its correction.

IREN traded down -6.95% to $41.78 during regular trading versus the prior session's close of $44.90. The decline tracked a broad crypto selloff, with Bitcoin down -2.91% and Ethereum down -4.41% to multi-month lows, pressuring IREN's remaining mining-linked exposure.

CRDO was down -13.68% to $244.13 during Tuesday's regular session, versus Monday's close of $282.82. The drop came amid a broad optical/memory chip selloff; the PHLX Semiconductor Index fell roughly -5.6%, its worst session since early July.

SMTC dropped -13.13% to $133.97 during Tuesday's regular session as of 1:53 p.m. ET, versus Monday's close of $154.22, after premarket weakness accelerated intraday. The decline was a sharp reversal from Monday's +9.9% surge tied to the $62 million Compal cellular-module divestiture and Stifel's Buy reiteration, leaving the stock vulnerable to profit-taking.

KALU shares fell -12.95% to $161.48 in Tuesday's regular session, versus a prior close of $185.50. The decline followed Kaiser Aluminum's announcement that Fred Stephan, an Amcor veteran, will succeed Keith Harvey as president and CEO effective November 1, 2026.

AAOI is down -13.71% in regular trading, last at $133.66 versus Monday's close of $154.89. The drop is part of a broad optical-communications selloff; Fabrinet fell about -14% after its beat-and-record quarter was seen as already priced in, dragging AAOI and peers lower.